Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Operating Expenses: 2015-2024

Historic Operating Expenses for UroGen Pharma (URGN) over the last 10 years, with Dec 2024 value amounting to $178.3 million.

  • UroGen Pharma's Operating Expenses rose 28.03% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $218.3 million, marking a year-over-year increase of 32.78%. This contributed to the annual value of $178.3 million for FY2024, which is 28.38% up from last year.
  • According to the latest figures from FY2024, UroGen Pharma's Operating Expenses is $178.3 million, which was up 28.38% from $138.9 million recorded in FY2023.
  • In the past 5 years, UroGen Pharma's Operating Expenses registered a high of $178.3 million during FY2024, and its lowest value of $135.2 million during FY2021.
  • For the 3-year period, UroGen Pharma's Operating Expenses averaged around $151.0 million, with its median value being $138.9 million (2023).
  • Per our database at Business Quant, UroGen Pharma's Operating Expenses fell by 1.71% in 2021 and then increased by 28.38% in 2024.
  • UroGen Pharma's Operating Expenses (Yearly) stood at $137.5 million in 2020, then declined by 1.71% to $135.2 million in 2021, then increased by 0.42% to $135.7 million in 2022, then grew by 2.32% to $138.9 million in 2023, then grew by 28.38% to $178.3 million in 2024.